MedTrace Logo

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

NCT00553124 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 3400

Last updated 2014-01-10

No results posted yet for this study

Summary

RATIONALE: Studying different factors that effect patients with newly diagnosed bladder cancer may help doctors learn more about the disease, improve the ability to plan cancer treatment, and help patients live more comfortably.

PURPOSE: This clinical trial is studying different factors affecting patients with newly diagnosed bladder cancer.

Conditions

Interventions

DRUG

selenium

DRUG

vitamin E

PROCEDURE

biopsy

PROCEDURE

chemoprevention

PROCEDURE

cryopreservation

PROCEDURE

cytology specimen collection procedure

PROCEDURE

diagnostic procedure

PROCEDURE

gene expression analysis

PROCEDURE

immunohistochemistry staining method

PROCEDURE

laboratory biomarker analysis

PROCEDURE

medical chart review

PROCEDURE

mutation analysis

PROCEDURE

polymerase chain reaction

PROCEDURE

quality-of-life assessment

PROCEDURE

questionnaire administration

PROCEDURE

study of socioeconomic and demographic variables

Sponsors & Collaborators

  • University Hospital Birmingham

    lead OTHER

Principal Investigators

  • K. K. Cheng, MD · University Hospital Birmingham

Study Design

Purpose
PREVENTION

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00553124 on ClinicalTrials.gov